Stability Indicating RP-HPLC method development and validation for simultaneous quantification of antihistaminic & anti-asthmatic drug in bulk and tablet dosage form
Journal of Pharmaceutical and Biological Sciences · 28.08.2020 · 8 (1) · 12-22
DOI: 10.18231/j.jpbs.2020.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biological Sciences, online erschienen am 15.08.2020. Verfasst von Dilip A. Patil und 4 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Patil, D. A., Sonawane, J. K., Jadhav, B. S., Jadhav, S. L., & Patil, P. B. (2020). Stability Indicating RP-HPLC method development and validation for simultaneous quantification of antihistaminic & anti-asthmatic drug in bulk and tablet dosage form. Journal of Pharmaceutical and Biological Sciences, 8(1), 12-22. https://doi.org/10.18231/j.jpbs.2020.003
Vancouver
Patil DA, Sonawane JK, Jadhav BS, Jadhav SL, Patil PB. Stability Indicating RP-HPLC method development and validation for simultaneous quantification of antihistaminic & anti-asthmatic drug in bulk and tablet dosage form. Journal of Pharmaceutical and Biological Sciences. 2020;8(1):12-22. doi:10.18231/j.jpbs.2020.003
BibTeX
@article{Patil2020,
author = {Patil, Dilip A. and Sonawane, Jitendra K. and Jadhav, Balasaheb S. and Jadhav, Satish L. and Patil, Prashant B.},
title = {Stability Indicating RP-HPLC method development and validation for simultaneous quantification of antihistaminic & anti-asthmatic drug in bulk and tablet dosage form},
journal = {Journal of Pharmaceutical and Biological Sciences},
year = {2020},
volume = {8},
number = {1},
pages = {12--22},
doi = {10.18231/j.jpbs.2020.003}
}
EUVIMED